Research Roundup

This week’s research roundup features a multicenter retrospective study on clinicopathologic predictors of renal outcomes in light chain cast nephropathy.

This week’s research roundup features a study on utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.

This week’s research roundup features a study on the contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort.

This week’s research roundup features a study on hippocampal avoidance during whole-brain radiotherapy, plus memantine for patients with brain metastases.

This week’s research roundup features a study on the epidemiology, natural history, and optimal management of neurohypophyseal germ cell tumors.

This week’s research roundup features a study on the impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain Amyloidosis.

This week’s research roundup features a study on imaging biomarkers of Alzheimer's disease in Multiple Sclerosis.

This week’s research roundup features an assessment of the predictive value of outpatient smartphone videos for diagnosis of epileptic seizures.

This week’s research roundup features a study on how abnormal expression of programmed death-1 (PD-1) ligand-1(PD-L1) in cancer cells play a crucial role in cancer immune evasion and progression.

This week’s research roundup features a study the identification of a novel homozygous multi-exon duplication in RYR2 among children with exertion-related unexplained sudden deaths in the Amish community.

This week's research roundup features a study on RINT1 bi-allelic variations that cause infantile-onset recurrent acute liver failure and skeletal abnormalities.

This week's research roundup features a study on late relapses in patient with diffuse large b-cell lymphoma who were treated with immunochemotherapy.

This week's research roundup features research on the phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human pappillomavirus-associated oropharynx squamous cell carcinoma.